BookSanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala.
Summary: This book covers the latest advances in non-muscle invasive bladder cancer care. It provides a review of the available evidence base for the efficacy of a range of therapeutic techniques, diagnostic procedures and risk factors. Management of Non-Muscle Invasive Bladder Cancer features detailed guidance in uniformly formatted chapters on how to properly apply a range of available therapeutic treatments relevant for patient care. It is a valuable resource for all trainee and practising medical professionals who treat these patients.
Contents:
Intro; Preface; Acknowledgements; Contents; About the Authors; Part I Background and Pathology on Bladder Cancer; 1 Background on Bladder Cancer; References; 2 Introduction to Bladder Cancer Type and Therapy; References; Part II Histological Variants in Bladder Cancer; 3 Histological Variants in Bladder Cancer-Sqaumous Cell Carcinoma and Squamous Differentiation; References; 4 Histological Variants in Bladder Cancer-Adenocarcinoma; 4.1 Histopathology of Bladder Adenocarcinoma; 4.2 Survival Outcomes in Adenocarcinoma of the Urinary Bladder 4.3 Surgical Management of Adenocarcinoma of the Bladder4.4 Urachal Adenocarcinoma-Surgical Management; 4.5 Chemotherapy in Metastatic Adenocarcinoma of the Bladder; References; 5 Histological Variants in Bladder Cancer-Sarcomatoid Differentiation; 5.1 Histopathology of Sarcomatoid Bladder Tumours; 5.2 Management in Paediatric Cases; 5.3 Clinical Presentation, Biphasic, Monophasic Components of Sarcomatoid Bladder Cancer; 5.4 Surgical Management of Sarcomatoid Differentiation of Bladder Cancer; 5.5 Survival Outcomes in Sarcomatoid Differentiation of Bladder Cancer; References 6 Histological Variants in Bladder Cancer-Carcinosarcoma6.1 Histopathology of Carcinosarcoma of the Bladder; 6.2 Clinical Presentation of Carcinosarcoma of the Bladder; 6.3 Surgical Management of Carcinoma of the Bladder; 6.4 Survival Outcomes and Prognosis in Carcinosarcoma of the Bladder; References; 7 Histological Variants in Bladder Cancer-Small Cell Carcinoma; 7.1 Variant Histology in Bladder Cancer-Small Cell Incidence and Histopathology; 7.2 Histological Variants in Bladder Cancer-Small Cell Treatment; 7.3 Bladder Sparing in Small Cell Carcinoma 7.4 Histological Variants in Bladder Cancer-Small Cell Survival Outcomes7.5 Histological Variants in Small Cell Carcinoma of the Urinary Bladder-Radiotherapy; 7.6 Cranial Irradiation in Small Cell Bladder Cancer; References; 8 Histological Variants-Plasmacytoid Bladder Cancer; 8.1 Diagnostics in Plasmacytoid Bladder Cancer; 8.2 Histological Variants-Clinical Presentation of Plasmacytoid Bladder Cancer; 8.3 Histological Variants-Histopathology of Plasmacytoid Bladder Cancer; 8.4 Histological Variants-Surgical Management of Plasmacytoid Bladder Cancer 8.5 Metastatic Spread of Plasmacytoid Bladder Cancer8.6 Surgical and Adjuvant Management in Plasmacytoid Bladder Cancer; 8.7 Prognosis in Plasmacytoid Bladder Cancer; 8.8 Metastatic Pattern of Spread-Plasmacytoid Bladder Cancer; 8.9 Systematic Chemotherapy in Plasmacytoid Bladder Cancer; References; Part III Epidemiology and Risk Factors in Bladder Cancer; 9 Introduction to Epidemiology of Bladder Cancer; 9.1 Smoking; 9.2 Occupational Exposure; 9.3 Age and Gender Related Disease; References; 10 Epidemiology, Risk Factors and Occupational Hazards-A Systematic Review; References